Live Breaking News & Updates on Prnewswire Eiger Biopharmaceuticals Inc|Page 2

Stay updated with breaking news from Prnewswire eiger biopharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO

Prioritizing resources to advance avexitide in hyperinsulinemic hypoglycemia indicationsActive discussions underway with potential partners to advance late-stage virology programsReduction in workforce executed to align with focus on avexitide; ext. ....

Aljanae Reynolds , Progeroid Laminopathies , Sylvia Wheeler , Bristol Myers Squibb , Thomas Dietz , Bluesphere Bio , David Apelian , Achillion Pharmaceuticals Inc , Prnewswire Eiger Biopharmaceuticals Inc , Schering Plough , Regulatory Affairs , Eiger Biopharmaceuticals Inc , Chief Executive Officer , Chief Operating Officer , Post Bariatric Hypoglycemia , Breakthrough Therapy , Pediatric Disease , Processing Deficient Progeroid , Based Regimens , Executive Medical Officer , Senior Clinical Advisor , Executive Vice President , Chief Medical Officer , Achillion Pharmaceuticals , Private Securities Litigation Reform Act , Quarterly Report ,

Eiger BioPharmaceuticals to Host Business Update Call Tomorrow

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies. ....

Aljanae Reynolds , Sylvia Wheeler , Eiger Biopharmaceuticals Inc , Prnewswire Eiger Biopharmaceuticals Inc , Call Details , Eiger Biopharmaceuticals ,

Eiger BioPharmaceuticals to Host Business Update Call Tomorrow

Company to host conference call and live webcast on Thursday, June 29, at 8:30 am ETPALO ALTO, Calif., June 28, 2023 /PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development o. ....

Aljanae Reynolds , Sylvia Wheeler , Prnewswire Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals Inc , Call Details ,

Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sylvia Wheeler , Aljanae Reynolds , Jamesa Vollins , Prnewswire Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals Inc , Compensation Committee Of Eiger Board Directors , General Counsel , Chief Compliance Officer , Corporate Secretary , Compensation Committee , Eiger Biopharmaceuticals , Nasdaq Listing Rule ,

Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

/PRNewswire/ Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies. ....

David Apelian , Sylvia Wheeler , Aljanae Reynolds , Progeroid Laminopathies , Company Annual Report On Form , Prnewswire Eiger Biopharmaceuticals Inc , National Institutes Of Health , Eiger Biopharmaceuticals Inc , Anges Inc , Complete Randomization , Startup Activities , Cash Equivalents , Short Term Debt Securities , Based Regimens , Peginterferon Lambda , National Institutes , Processing Deficient Progeroid , Rare Metabolic , Pediatric Disease , Priority Review Voucher , Full Year , Distribution Agreement , Private Securities Litigation Reform Act , Quarterly Report , Annual Report , Consolidated Statements ,